NATH BIO-GENES (I) LTD (NATHBIOGEN) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1993, Nath Bio-Genes Ltdis in the business of Production, Processing,and Marketing of Hybrid and GM Seeds[1]

NATHBIOGENUpdated 31 Aug 2026, 18:52

Nath Bio-genes (i) Ltd

Market Cap

₹301Cr.

Current Price

₹158

High / Low

₹207/126

Stock P/E

6.90

ROE5.83%
ROCE7.18%
Book Value₹363
Face Value₹10.0
Dividend Yield1.26%

About

Incorporated in 1993, Nath Bio-Genes Ltdis in the business of Production, Processing,and Marketing of Hybrid and GM Seeds[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days11413013317519115914713615213912271
Inventory Days3,8404,7434,388
Days Payable1,3091,406586
Cash Conversion Cycle1141302,6653,5121911591471363,95413912271
Working Capital Days190259273447442416450427416343316258
ROCE %26%14%10%9%8%9%10%5%7%7%7%7%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 31 August 2026 at 18:52


Designed & Shipped by Harshit Bansal